SCHEMBL1806158

SCHEMBL1806158

COc1cc2ncnc(NCc3cc(S(N)(=O)=O)ccc3OCC(F)(F)F)c2cc1OC

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BRAF P15056 4/20 0.61
TNNI3K Q59H18 4/20 0.61
MAPK1 P28482 3/20 0.53
ALDH1A1 P00352 3/20 0.52
HTT P42858 3/20 0.52
HPGD P15428 2/20 0.52
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 3/20 0.51
ENPP1 P22413 3/20 0.50
EGFR P00533 4/20 0.49
LMNA P02545 1/20 0.49
LCK P06239 1/20 0.48
MEN1 O00255 1/20 0.48
LRRK2 Q5S007 1/20 0.47
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1804510 0.99 BRAF (0.60) BRAFTNNI3KMAPK1ALDH1A1HTT
SCHEMBL1805724 0.96 BRAF (0.63) BRAFTNNI3KMAPK1ALDH1A1HTT
SCHEMBL1807903 0.96 BRAF (0.63) BRAFTNNI3KMAPK1ALDH1A1HTT
SCHEMBL1804741 0.94 BRAF (0.55) BRAFTNNI3KMAPK1ALDH1A1HTT
SCHEMBL1806081 0.94 BRAF (0.64) BRAFTNNI3KMAPK1ALDH1A1HTT
SCHEMBL1805541 0.94 BRAF (0.54) BRAFTNNI3KMAPK1ALDH1A1HTT
SCHEMBL1808229 0.93 BRAF (0.53) BRAFTNNI3KMAPK1ALDH1A1HTT
SCHEMBL1806484 0.92 TNNI3K (0.58) BRAFTNNI3KMAPK1ALDH1A1HTT
SCHEMBL1806487 0.91 BRAF (0.51) BRAFTNNI3KMAPK1KMT2AEGFR
SCHEMBL1806390 0.90 MAPK1 (0.54) BRAFTNNI3KMAPK1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP claimed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO claimed
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP disclosed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO disclosed